Abstract
Meeting abstracts Immunotherapy has emerged as a promising treatment strategy for the control of HPV-associated malignancies. Various therapeutic HPV vaccines have elicited potent antigen-specific CD8+ T cell mediated antitumor immune responses in preclinical models and are currently being tested
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have